Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCNF)

Avicanna Inc (AVCNF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AVCNF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1668 +88.55%
on 05/12/22
0.3669 -14.28%
on 04/29/22
+0.0978 (+45.13%)
since 04/27/22
3-Month
0.1668 +88.55%
on 05/12/22
0.3669 -14.28%
on 04/29/22
-0.0118 (-3.62%)
since 02/25/22
52-Week
0.1668 +88.55%
on 05/12/22
1.2399 -74.64%
on 07/14/21
-0.5355 (-63.00%)
since 05/27/21

Most Recent Stories

More News
Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus™ Branded THC and CBD Extracts to Portugal

This export marks Avicanna’s 15th international new market for Avicanna...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Reports Q1 2022 Financial Statement and Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Announces Closing of Strategic Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market

Avicanna introduces the rare cannabinoid CBG into its RHO Phyto product formulary which includes oral, sublingual, and transdermal formulations RHO...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company

TORONTO, April 13, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG

The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products will be commercialized...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

$3.3M in revenue representing 108% Y-Y growth, significant growth in finished product sales Total of 4 brands, 16 SKU’s and 35 “cannabis...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma

The proposed partnership will encompass three potential strategic pillars across supply of API, commercialization of prescription products, and...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)
Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance

Projected revenue of $9M for fiscal 2022 through its Canadian and global operations, including the international commercialization of cannabinoid-based...

AVCN.TO : 0.4150 (+15.28%)
AVCNF : 0.3145 (+11.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.3497
2nd Resistance Point 0.3321
1st Resistance Point 0.3233
Last Price 0.3145
1st Support Level 0.2969
2nd Support Level 0.2793
3rd Support Level 0.2705

See More

52-Week High 1.2399
Fibonacci 61.8% 0.8300
Fibonacci 50% 0.7034
Fibonacci 38.2% 0.5767
Last Price 0.3145
52-Week Low 0.1668

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar